Recruiting Hemophilia Studies in Indianapolis
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A
WP44714 is a Phase I/II, open-label, non-randomized, global, multicenter trial consisting of two parts: * Part 1 is a multiple-ascending dose (MAD) study in adult and adolescent male participants wit...
Emicizumab in Patients With Acquired Hemophilia A
This is a phase II multicenter open-label, single-arm prospective study to evaluate the efficacy of prophylactic emicizumab administered on a scheduled basis to prevent bleeds in patients with acquire...
About Hemophilia Clinical Trials in Indianapolis
Hemophilia is a rare genetic bleeding disorder in which blood does not clot properly due to deficiency of clotting factors. Hemophilia A (factor VIII) and hemophilia B (factor IX) are the most common types. Treatment includes factor replacement therapy and newer approaches like gene therapy.
There are currently 2 hemophilia clinical trials recruiting participants in Indianapolis, INDIANA. These studies are seeking a combined 111 participants. Research is being sponsored by Hoffmann-La Roche, University of Washington. Clinical trial participation is free and participants receive study-related medical care at no cost.
Hemophilia Clinical Trials in Indianapolis — FAQ
Are there hemophilia clinical trials in Indianapolis?
Yes, there are 2 hemophilia clinical trials currently recruiting in Indianapolis, INDIANA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Indianapolis?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Indianapolis research site will contact you about next steps.
Are clinical trials in Indianapolis free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Indianapolis studies also compensate for your time and travel.
What hemophilia treatments are being tested?
The 2 active trials in Indianapolis are testing new therapies including novel drugs, biologics, and treatment approaches for hemophilia.
Data updated March 2, 2026 from ClinicalTrials.gov